Alirocumab 150mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £15,576,288 of indicative cost of Alirocumab 150mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 9.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Alirocumab 150mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Alirocumab 150mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hpls Of Leicester Nhs Trust | £833,616 |
| Univ Hpl B/Ham Nhs Foundation Trust | £598,080 |
| Guy's & St Thomas' Nhs Foundation Trust | £575,400 |
| Barts Health Nhs Trust | £557,592 |
| Walsall Healthcare Nhs Trust | £483,672 |
| Hampshire Hospitals Nhs Foundation Trust | £443,352 |
| Aintree University Hospital Nhs Ft | £438,480 |
| Leeds Teaching Hpls Nhs Trust | £432,768 |
| Oxford University Hospitals Nhs Ft | £409,752 |
| Buckinghamshire Hospitals Nhs Trust | £395,136 |
The primary-care picture
Alirocumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Alirocumab medicine page.